role of injectable platelet rich fibrin in periodontal diseases

Clinical and radiographic evaluation of injectable platelet rich fibrin polymerization with hydroxyapatite bone graft in the treatment of grade ii furcation defects- a randomized controlled clinical study. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057296

Enrollment

Registered

2023-09-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K039- Disease of hard tissues of teeth,unspecified

Interventions

Intervention1: Hydroxapatite Bone Graft in grade ii furcation defects: All subjects in the control group will be treated with Hydroxyapatite Bone Graft in grade ii Furcation Defects. vertical relative

Eligibility

Inclusion criteria

Inclusion criteria: Clinical evidence of buccal furcation defect = 3 mm measured using Naber’s probe. Vertical probing depth =5mm measured using unc-15 probe. radiographic evidence of furcation defect.

Exclusion criteria

Exclusion criteria: Systemic diseases. Pregnant and lactating women. Grade-III mobility. Teeth with incorrect endodontic treatment or restorative treatment.

Design outcomes

Primary

Measure	Time frame
To fill the defectTimepoint: baseline & 3 months	—

Secondary

Measure	Time frame
Probing pocket depth Vertical Relative attachment level Timepoint: baseline & 3months	—

Countries

India

Contacts

Public ContactDRGJAGADISH REDDY

Kamineni Institute of Dental Sciences

drjagadishreddy@gmail.com9949801470

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026